• Statistics

    • Canada has one of the highest incidence and prevalence rates of inflammatory bowel disease in the world.
    • The total direct medical costs for IBD were $700 million in 2008.
    • In 2008, the cost of prescription drugs for the treatment of Canadian patients with IBD was $162 million ($809/patient)
    • Costs associated with additional physician visits and outpatient surgeries cost $134 million in 2008.
    • Indirect costs associated with IBD total in excess of $1 billion with the main contributor being long-term work loss.
    • Sick leave and absenteeism attributes to IBD cost the Canadian economy $104.2 million per year.
    • Absenteeism and early retirement due to IBD is estimated to cost the Canadian market $746 million
    • In a single year, the Canadian workforce suffers a productivity loss of $138 million due to short-term absences of IBD patients.
    • In 2008, there were an estimated 250,000 Canadians with IBD
    • The average age of IBD onset coincides with an individual's most important socioeconomic period of their life. As such, the indirect costs of IBD are enormous as symptom severity may prevent a patient from realizing their career potential or family creation.
    • Prince Edward Island has the highest prevalence of IBD in Canada. Ontario has the most IBD cases.
    • Malnutrition and blood disorders are common conditions in IBD patients found to be caused by avoiding food items either because of existing symptoms or concern that they may bring on symptoms.
    • Complimentary and alternative medicines are used at some point by half of all IBD patients. Costs associated with these medicines are not covered by health care plans.
    • Almost half of IBD patients have additional health issues affecting their joints, skin, eyes, and biliary tract that may be more debilitating than the bowel symptoms.
    • The next generation of IBD drugs, referred to as "biologicals", cost $10,000 per patient per year. These drugs have been credited for reducing hospitalization and surgery costs for IBD patients.

Enhancing lifelong health

The Canadian Digestive Health Foundation believes our ability to help establish, enrich and protect a healthy gut microbiota is the key to lifelong health